Subclinical acute rejection: Is it a cause of chronic rejection in renal transplantation?

Transplantation Reviews

Volumn 14, Issue 3, 2000, Pages 131-137

  Rush, David N ^a,b   Jeffery, John ^a   Nickerson, Peter ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Department of Internal Medicine ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000858026     PISSN: 0955470X     EISSN: None     Source Type: Journal    
DOI: 10.1053/trre.2000.7151     Document Type: Article

References (47)

1. Paul L: Chronic renal transplant loss. Kidney Int 1995, 47:1491.
2. Tullius S, Tilney N: Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 1995, 59:313
3. Halloran P, Melk A, Barth C: Rethinking chronic allograft nephropathy: The concept of accelerated senescence. J Am Soc Nephrol 1999, 10:167
4. Mathew TH, for the Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group: A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: Results at 3 years. Transplantation 1998, 65:1450
5. Bjorn N, Moore R, Amiot P, et al for the CHIB 201 International Study Group: Randomized trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. Lancet 1997, 350:1193
6. Vincenti F, Kirkman R, Light S, et al for the Daclizumab Triple Therapy Study Group: Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. N Engl J Med 1998, 338:161
7. Racusen LC, Solez K, Colvin RB, et al: The Banff 97 working classification of renal allograft pathology. Kidney Int 1999, 55:713
8. Rush DN, Henry SF, Jeffery JR, et al: Histological findings in early routine biopsies of stable renal allograft recipients. Transplantation 1994, 57:208
9. Rush DN, Jeffery JR, Gough J: Sequential protocol biopsies in renal transplant patients. Clinico-pathologic correlations using the Banff schema. Transplantation 1995, 59:511
10. Almond P, Matas A, Gillingham K, et al: Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993, 55:752
11. Tesi R, Henry M, Elkhammas E, et al: Predictors of long-term primary cadaveric renal transplant survival. Clin Transplant 1993, 7:345
12. Matas AJ, Gillingham KJ, Payne WD, et al: The impact of an acute rejection on long-term renal allograft survival (t1/2). Transplantation 1994, 57:857
13. Massy Z, Guijarro C, Wiederkehr M, et al: Chronic renal allograft rejection: Immunologic and nonimmunologic risk factors. Kidney Int 1996, 49:518
14. Flechner S, Modlin C, Serrano D, et al: Determinants of chronic renal allograft rejection in cyclosporine-treated recipients. Transplantation 1996, 62:1235
15. Sijpkens YW, Doxiadis II, De Fijter JW, et al: Sharing cross-reactive groups of MHC class I improves long-term graft survival. Kidney Int 1999, 56:1920
16. Hunsicker LG, Bennett LE: Design of trials of methods to reduce late renal allograft loss: The price of success. Kidney Int 1995, 52 (suppl):S120
17. van Saase JLCM, van der Woude FJ, Thorogood J, et al: The relation between acute vascular and interstitial renal allograft rejection and subsequent chronic rejection. Transplantation 1995, 59:1280
18. Kooijmans-Coutiño MF, Hermans J, Schrama E, et al: Interstitial rejection, vascular rejection and diffuse thrombosis of renal allografts: Predisposing factors, histology, immunohistochemistry, and relation to outcome. Transplantation 1996, 61:1338
19. Nickeleit V, Vamvakas EC, Pascual M, et al: The prognostic significance of specific arterial lesions in acute renal allograft rejection. J Am Soc Nephrol 1998, 9:1301
20. Gaber LW, Moore LW, Gaber AO, et al: Utility of standardized histological classification in the management of acute rejection. Transplantation 1998, 64:376
21. Macdonald FI, Ashraf S, Picton M, et al: Banff criteria as predictors of outcome following renal transplantation. Nephrol Dial Transplant 1999, 14:1692
22. Basadonna G, Matas A, Gillingham K, et al: Early versus late acute renal allograft rejection: Impact on chronic rejection. Transplantation 1993, 55:993
23. Colvin RB, Cohen AH, Saiontz C, et al: Evaluation of pathologic criteria for acute renal allograft rejection: Reproducibility, sensitivity, and clinical correlation. J Am Soc Nephrol 1997, 8:1930
24. d'Ardenne AJ, Dunnill MS, Thompson JF, et al: Cyclosporin and renal graft histology. J Clin Pathol 1986, 39:145
25. Serón D, Diaz-Gallo C, Grinyó JM, et al: Characterization of interstitial infiltrate in early renal allograft biopsies in patients with stable renal function. Transplant Proc 1991, 23:1267
26. Nickerson P, Jeffery J, Gough J, et al: Identification of clinical and histopathologic risk factors for diminished renal function 2 years post-transplant. J Am Soc Nephrol 1998, 9:482
27. Legendre C, Thervet E, Skhiri H, et al: Histologic features of chronic allograft nephropathy revealed by protocol biopsies in kidney transplant recipients. Transplantation 1998, 65:1506
28. Mazzucchi E, Lucon AM, Nahas WC, et al: Histological outcome of acute cellular rejection in kidney transplantation after treatment with methylprednisolone. Transplantation 1999, 67:430
29. Gaber LW, Moore LW, Gaber AO, et al: Correlation of histology to clinical rejection reversal: A thymoglobulin multicenter trial report. Kidney Int 1999, 55:2415
30. Burdick JF, Beschorner WE, Smith WJ, et al: Characteristics of early routine renal allograft biopsies. Transplantation 1984, 38:679
31. Hanas E, Larsson E, Fellstrom B, et al: Safety aspects and diagnostic findings of serial allograft biopsies, obtained by an automatic technique with a midsize needle. Scan J Urol Nephrol 1992, 26:413
32. Rush D, Nickerson P, Gough J, et al: Beneficial effects of treatment of early subclinical rejection: A randomized study. J Am Soc Nephrol 1998, 9:2129
33. Nickerson P, Jeffery JR, Gough J, et al: Effect of increasing baseline immunosuppression on the prevalence of clinical and subclinical rejection: A pilot study. J Am Soc Nephrol 1999, 10:1801
34. Kobayashi T, Yokoyama I, Uchida K, et al: HLA-DRB1 matching as a recipient selection criterion in cadaveric renal transplantation. Transplantation 1993, 55:1294
35. Beckingham IJ, Dennis MJS, Bishop MC, et al: Effect of human leukocyte antigen matching on the incidence of acute rejection in renal transplantation. Br J Surg 1994, 81:574
36. McKenna R, Lee K, Gough J, et al: Matching for private or public HLA epitopes reduces acute rejection episodes and improves 2 year renal allograft function. Transplantation 1998, 66:38
37. Rush DN, Grimm P, Gough J, et al: Predicting rejection: Is early diagnosis achievable and important? Graft 1999, 2(suppl): S31
38. Grimm PC, McKenna R, Nickerson P, et al: Clinical rejection is distinguished from subclinical rejection by increased infiltration by a population of activated macrophages, J Am Soc Nephrol 1999, 10:1582
39. Lipman ML, Shen Y, Jeffery JR, et al: Immune-activation gene expression in clinically stable renal allograft biopsies: Molecular evidence for subclinical rejection. Transplantation 1998, 66:1673
40. Ramos EL, Barri YM, Croker BP, et al: Thromboxane synthase expression in renal transplant patients with rejection. Transplantation 1995, 59:490
41. 2 in renal allograft rejection. Lancet 1981, 2:431
42. Smith SD, Wheeler MA, Zhang R, et al: Nitric oxide synthase induction with renal transplant rejection or infection. Kidney Int 1996, 50:2088
43. Grimm PC, Rush DN, Stern E, et al: Chemokine gene expression (RANTES and MIP-1) in asymptomatic human renal allograft rejection. J Am Soc Nephrol 1995, 6:1057
44. Kirk AD, Jacobson LM, Heisey DM, et al: Clinically stable human renal allografts contain histological and RNA-based findings that correlate with deteriorating graft function. Transplantation 1999, 68:1578
45. Knight RJ, Kerman RH, Welsh M, et al: Chronic rejection in primary renal allograft recipients under cyclosporine-prednisone immunosuppressive therapy. Transplantation 1991, 51: 355
46. Saad R, Gritsch HA, Shapiro R, et al: Clinical significance of renal allograft biopsies with "borderline changes," as defined in the Banff schema. Transplantation 1997, 64:992
47. Solez K, Vincenti F, Filo RS: Histopathologic findings from 2-year protocol biopsies from a US multicenter kidney transplant trial comparing tacrolimus versus cyclosporine. Transplantation 1998, 66:1736